Provided by Tiger Fintech (Singapore) Pte. Ltd.

HCW Biologics Inc.

10.05
+4.8492.90%
Post-market: 11.721.67+16.62%19:59 EDT
Volume:37.61M
Turnover:496.57M
Market Cap:11.29M
PE:-0.32
High:17.80
Open:15.00
Low:8.22
Close:5.21
Loading ...

Top Midday Gainers

MT Newswires Live
·
04 Feb

Dow Falls 150 Points; ISM Manufacturing PMI Rises In January

Benzinga
·
04 Feb

S&P 500 Down Over 1%; Tyson Foods Posts Upbeat Results

Benzinga
·
03 Feb

HCW Biologics Advances with FDA Clearance for Trial

TIPRANKS
·
03 Feb

BUZZ-HCW Biologics rises as US FDA approves trial for hair loss treatment

Reuters
·
03 Feb

HCW Biologics Says FDA Approves Trial of HCW9302 to Treat Alopecia Areata; Shares Rise Pre-Bell

MT Newswires Live
·
03 Feb

HCW Biologics receives clearance of IND from FDA for HCW9302

TIPRANKS
·
03 Feb

HCW Biologics Inc - HCW9302 Shows Efficacy in Treating Autoimmune Diseases

THOMSON REUTERS
·
03 Feb

HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-in-Human Phase 1 Clinical Trial

THOMSON REUTERS
·
03 Feb

HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial

GlobeNewswire
·
03 Feb

HCW Biologics Insiders Placed Bullish Bets Worth US$2.50m

Simply Wall St.
·
23 Jan

HCW Biologics CEO to address opportunities, challenges in biomanufacturing

TIPRANKS
·
15 Jan

HCW Biologics’ Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025

GlobeNewswire
·
15 Jan

HCW Biologics Shares Fall Amid Delisting Notice From Nasdaq

MT Newswires Live
·
24 Dec 2024

HCW Biologics receives notice on failing to regain compliance from Nasdaq

TIPRANKS
·
23 Dec 2024

HCW Biologics Inc. Received Nasdaq Staff Determination Letter

THOMSON REUTERS
·
23 Dec 2024

HCW Biologics Inc. Received NASDAQ Staff Determination Letter

GlobeNewswire
·
23 Dec 2024

HCW Biologics Secures Strategic Agreements and Funding to Propel Growth and Innovation

TIPRANKS
·
27 Nov 2024

HCW Biologics Expands with New Financial Agreements

TIPRANKS
·
21 Nov 2024

HCW Biologics prices $6.9M registered direct offering at $1.03 per share

TipRanks
·
20 Nov 2024